People · Operator
Named in public records as an officer, director or promoter · active 2016–2024 · HR / Worktech, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vahan Inc. | — | HR / Worktech | Series A | $21.9M | $70.1M | 2021 |
| Citius Pharmaceuticals, Inc. | — | Pharmaceuticals | Series B | $21.2M | $542.1M | 2016 |
Suren Dutia at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Suren Dutia on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Myron Holubiak | 1 | 4 |
| Leonard Mazur | 1 | 3 |
| Howard Safir | 1 | 2 |
| Carol Webb | 1 | 2 |
| Jaime Bartushak | 1 | 1 |
| William Kane | 1 | 1 |
| Madhav Krishna | 1 | 1 |
| Rishi Srivastava | 1 | 1 |
| Eugene Holuka | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.